Statement of Federal Trade Commission Chairman Jon Leibowitz on Ending “Pay-for-Delay” Drug Settlements, Praises Inclusion in President’s Health Care Proposal

“When drug companies agree not to compete, consumers lose,” said Federal Trade Commission Chairman Jon Leibowitz. “Ending pay-for-delay settlements will help control drug costs. We’re delighted about the President’s resolute support for this bipartisan initiative.”

MEDIA CONTACT:

Office of Public Affairs
202-326-2181

 

(JDL stmt)

Reporter Resources: Pay-for-Delay in the Pharmaceutical Industry

Pay-For-Delay: How Drug Company Pay-Offs Cost Consumers Billions: A Federal Trade Commission Staff Study (January 2010)

• Text of the FTC Staff Study